In CRC, METTL3-mediated m6A modification of GLUT1 mRNA enhances its translational efficiency, leading to increased glucose uptake, lactate production, and mTORC1 signaling activation, thereby driving tumor growth [112]. Here, SLC2A1 is linked to colorectal carcinoma.